VetClick
Menu Menu
Login

VetClick

/ News
Friday, 5th December 2025 | 2,161 veterinary jobs online | 97 people actively seeking work | 5,628 practices registered

Veterinary Industry News

Send us your news

Zoetis Hosts Free Webinar To Share Latest Knowledge Of Lungworm

4 days ago
137 views

Posted
1st December, 2025 13h50

Author
Zoetis


Zoetis UK Ltd today announced that it is inviting vets and vet nurses to join a free CPD webinar to discuss the latest knowledge on lungworm.

The webinar will be held on Wednesday 3 December 2025 at 7.30pm – 8.30pm and will be presented by guest speaker Jenny Helm Cert SAM Dip ECVIM-CA FHEA MRCVS EBVS and RCVS Specialist in Small Animal Medicine.

Dr Helm will explain the latest knowledge about lungworm in dogs, including an update on prevalence, clinical case management and treatment and prevention options. The session is worth one hour’s CPD.

“With the continued presence of lungworm in the UK we are proud to be able to share the latest information with the veterinary profession on the risks of this potentially deadly disease,” said Louise Longstaff, National Veterinary Manager at Zoetis UK. 

“Jenny will not only cover some of the challenges with diagnosing lungworm but will also discuss the latest prevention strategies including the use of Simparica Trio™. This is the only oral moxidectin licensed to treat A.vasorum in dogs in the UK*, which enables vets to tailor treatment based on their patient’s needs while still prescribing within the cascade*.”

To book the webinar please visit https://cloud.mc.zoetis.com/LungWormWebinar2025

For further information contact your Zoetis Account Manager or call Customer Support on 0345 300 8034.

About Zoetis

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees. For more information, visit www.zoetis.com.

Reference

*Simparica™ Trio SPC


More from Zoetis


You might be interested in...